Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 029793/0978 | |
| Pages: | 8 |
| | Recorded: | 02/12/2013 | | |
| Attorney Dkt #: | GWMP TO NERRE |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
6
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12464171
|
Filing Dt:
|
05/12/2009
|
|
Publication #:
|
|
Pub Dt:
|
11/19/2009
| | | | |
|
Title:
|
Novel Compounds
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/05/2013
|
Application #:
|
12989699
|
Filing Dt:
|
10/26/2010
|
|
Publication #:
|
|
Pub Dt:
|
03/03/2011
| | | | |
|
Title:
|
Spiro (Piperidine-4,2'-Pyrrolidine)-1-(3,5-Trifluoromethyl Phenyl) Methylcarboxamides As NK1 Tachikynin Receptor Antagonists
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/05/2013
|
Application #:
|
12989699
|
Filing Dt:
|
10/26/2010
|
| | | | | | |
PCT #:
|
EP2009055190
|
|
Title:
|
Spiro (Piperidine-4,2'-Pyrrolidine)-1-(3,5-Trifluoromethyl Phenyl) Methylcarboxamides As NK1 Tachikynin Receptor Antagonists
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/01/2013
|
Application #:
|
12991515
|
Filing Dt:
|
11/08/2010
|
|
Publication #:
|
|
Pub Dt:
|
03/10/2011
| | | | |
|
Title:
|
5-[5-[2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-2-METHYLPROPANOMETHYLPROPANOYLMETHYLAMINO]-4-(4-FLUORO-2-METHYLPHENYL)]-2-PYRIDINYL-2-ALKYL-PROLINAMIDE AS NK1 RECEPTOR ANTAGONISTS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
01/01/2013
|
Application #:
|
12991515
|
Filing Dt:
|
11/08/2010
|
|
Publication #:
|
|
Pub Dt:
|
03/10/2011
| | |
PCT #:
|
EP2009055700
|
|
Title:
|
5-[5-[2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-2-METHYLPROPANOMETHYLPROPANOYLMETHYLAMINO]-4-(4-FLUORO-2-METHYLPHENYL)]-2-PYRIDINYL-2-ALKYL-PROLINAMIDE AS NK1 RECEPTOR ANTAGONISTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/02/2014
|
Application #:
|
13681925
|
Filing Dt:
|
11/20/2012
|
|
Publication #:
|
|
Pub Dt:
|
06/06/2013
| | | | |
|
Title:
|
5-[5-[2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-2-METHYLPROPANOMETHYLPROPANOYLMETHYLAMINO]-4-(4-FLUORO-2-METHYLPHENYL)]-2-PYRIDINYL-2-ALKYL-PROLINAMIDE AS NK1 RECEPTOR ANTAGONISTS
|
|
|
Assignee
|
|
|
|
|
| C/O MOFO NOTICES LIMITED, CITYPOINT, ONE ROPEMAKER ST |
| LONDON, UNITED KINGDOM EC2Y 9AW |
|
|
Correspondence name and address
|
| |
GLAXOSMITHKLINE LLC
|
| |
FIVE MOORE DRIVE, PO BOX 13398
|
| |
MAIL STOP: BIDE C2111.2F
|
| |
RESEARCH TRIANGLE PK, NC 27529
|
Search Results as of:
05/30/2024 01:29 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
